CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-06 | DANIELS RONALD J Director | Sale | −61,031 | $63.72 | $3.9M | 16,991 |
| 2025-11-06 | DANIELS RONALD J Director | Option exercise · Stock Option (Right to Buy) | −61,031 | 30,523 | ||
| 2025-10-29 | MCCORMICK FRANK Director | Sale 10b5-1 | −111,755 | $65.48 | $7.3M | 766,583 |
| 2025-10-29 | MCCORMICK FRANK Director | Sale 10b5-1 | −31,116 | $66.20 | $2.1M | 735,467 |
| 2025-10-29 | MCCORMICK FRANK Director | Sale 10b5-1 | −3,497 | $67.52 | $236K | 731,970 |
| 2025-10-29 | MCCORMICK FRANK Director | Sale 10b5-1 | −8,598 | $68.50 | $589K | 723,372 |
| 2025-10-29 | MCCORMICK FRANK Director | Sale 10b5-1 | −43,393 | $69.24 | $3.0M | 679,979 |
| 2025-10-27 | MCCORMICK FRANK Director | Sale 10b5-1 | −1,641 | $65.00 | $107K | 878,338 |
| 2025-10-09 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −20,000 | $54.80 | $1.1M | 4,638,447 |
| 2025-10-09 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −20,000 | $54.80 | $1.1M | 835,686 |
| 2025-10-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,706 | $54.39 | $474K | 4,669,741 |
| 2025-10-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −11,294 | $55.09 | $622K | 4,658,447 |
| 2025-10-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,705 | $54.39 | $473K | 866,981 |
| 2025-10-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −11,295 | $55.09 | $622K | 855,686 |
| 2025-09-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −2,300 | $51.95 | $119K | 4,696,147 |
| 2025-09-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −16,800 | $53.16 | $893K | 4,679,347 |
| 2025-09-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −900 | $53.80 | $48K | 4,678,447 |
| 2025-09-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −2,300 | $51.96 | $120K | 893,386 |
| 2025-09-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −16,900 | $53.16 | $898K | 876,486 |
| 2025-09-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −800 | $53.80 | $43K | 875,686 |
Page 14 of 32 · 638 trades